WALDENSTRÖM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks Real-World impact of blood cancer drug
Disease control Recruiting nowThis study follows 705 adults with Waldenström's macroglobulinemia, chronic lymphocytic leukemia, marginal zone lymphoma, or follicular lymphoma who are taking zanubrutinib. Researchers want to see how the drug affects quality of life and how often patients need hospital care. Th…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
New drug trial aims to control rare blood cancer in chinese patients
Disease control Recruiting nowThis study tests the drug zanubrutinib in 18 Chinese adults who have Waldenström macroglobulinemia but have not yet received treatment. The goal is to see how well the drug controls the disease and to check for side effects. Participants take the drug by mouth, and doctors will m…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: BeiGene • Aim: Disease control
Last updated May 15, 2026 11:53 UTC